Rubbish Check
CBS MoneyWatch · July 21, 2026
source“GLP-1s are linked to a 17% drop in worker sick leave, new study finds”
R4/ 10
Selective
Rubbish Rating — 1 = base fact, 10 = pure rubbish
12345678910
In short
Rubbish Talk rates CBS MoneyWatch's claim that GLP-1s cut "worker sick leave" by 17% a 4/10 because the finding is specific to long-term (30+ day) sickness absence, and the underlying NBER paper found no significant effect on income, employment, or labor force participation, a caveat the article never mentions.
The Verdict
Selective. The 17% figure is accurate and the article does a decent job explaining Denmark's welfare quirks, but the headline compresses "long-term sickness leave" into generic "sick leave," and the piece omits the study's own finding of no measurable employment or income effect, which undercuts the productivity narrative it builds toward.
What actually happened
A new NBER working paper by Bock, Moshfegh, and Zhang used Danish administrative data to compare workers who started GLP-1 drugs early versus similar workers who started years later. They find that GLP-1 treatment reduces long-term sickness leave by 17.3%, with total fiscal benefits of approximately 1.3-1.5% of annual labor income per employed individual. Critically, the researchers do not detect statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.
Key facts
- Long-term sickness leave fell 17.3% among GLP-1 initiators versus later starters.
- The reduction in worker absences translates to savings of up to 1.5% of an individual's salary, or roughly $866 on average, per the study.
- The study defines long-term sick leave as illness-related absences lasting more than 30 days, and it draws on Danish worker and medication data, where employers cover the first 30 days of pay and government covers the rest.
- The paper found no statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.
What to watch for
Watch whether follow-up coverage picks up the paper's null employment and income results, since those complicate the "cost savings for workers" framing in the headline. Also watch for US-specific replication attempts: Zhang's claim that findings "could apply" to the American labor market is speculative and untested by this Danish dataset. Any coverage repeating the productivity/promotion angle without the null results deserves scrutiny.
About this scoreThe R-Score is Rubbish Talk's editorial opinion on how far a headline's framing sits from what the underlying facts support. It is a judgement about presentation and emphasis, not an allegation that any outlet has acted dishonestly. Every figure we rely on is linked under Receipts so you can check it yourself.
Related
